Prospective 11 years aspirin use, exposure Cohort, BMI, energy category. 104.52 vs 14.91 332/ >2 yrs follow-up 1.05 (0.66-1.65) Age: 40-70 intake, HRT use, g/day W menopausal Incidence, colon status, 104.52 vs 14.91 200/ cancer, >2 yrs 0.94 (0.53-1.65) multivitamin g/day follow-up supplement intake, physical activity, polyunsaturated fat, red meat intake, smoking status Incidence, rectal 104.52 vs 14.91 132/ cancer, >2 yrs 1.32 (0.61-2.84) g/day follow-up OCS, 379/ Incidence, vs 0-26.2 ≥96.4 Prospective 39 498 colorectal 1.07 (0.78-1.46) Sugawara, 2009 Cancer registry g/day Cohort, 9 years cancer, men COL40781 and death FFQ Age: 40-79 Japan certificates Incidence, colon vs 0-26.2 years, ≥96.4 229/ 1.11 (0.75-1.64) cancer, men g/day M/W
Prospective Cohort, Age: 40-70 W 11 years aspirin use, BMI, energy intake, HRT use, menopausal status, multivitamin supplement intake, physical activity, polyunsaturated fat, red meat intake, smoking status exposure category. 332/ >2 yrs follow-up 104.52 vs 14.91 g/day 1.05 (0.66-1.65) 200/ Incidence, colon cancer, >2 yrs follow-up 104.52 vs 14.91 g/day 0.94 (0.53-1.65) 132/ Incidence, rectal cancer, >2 yrs follow-up 104.52 vs 14.91 g/day 1.32 (0.61-2.84) Sugawara, 2009 COL40781 Japan OCS, Prospective Cohort, Age: 40-79 years, M/W 379/ 39 498 9 years Cancer registry and death certificates FFQ Incidence, colorectal cancer, men ≥96.4 vs 0-26.2 g/day 1.07 (0.78-1.46) 229/ Incidence, colon cancer, men ≥96.4 vs 0-26.2 g/day 1.11 (0.75-1.64)
CUP_colorectal_SLR_2016_RO.docx